Home » Authors » Jim Stommen

Jim Stommen

Articles

ARTICLES

'Second-tier' firms seen with a growing role as acquirers

May 26, 2005

Some clouds seen in sunny investing climate for sector

May 19, 2005

Choice of regulatory paths, relationship-building are key

May 17, 2005

‘Second-tier’ firms seen having a growing role as acquirers

May 16, 2005

By whatever name, taking some services outside seen growing

May 13, 2005

To attract partners and make alliances work, do homework

May 13, 2005

Some clouds seen in sunny investing climate for devices

May 12, 2005

Gathering puts big spotlight on Upper Midwest device sector

May 11, 2005

Split Rock raises $275M for first fund; Canaan adds $450M

May 5, 2005

Growth of med-tech sector is a boon to Ireland's economy

May 1, 2005

View All Articles by Jim Stommen

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...